Developing a safe and effective CAR T-cell immunotherapy for breast cancer: progress and pitfalls (2020)
Attributed to:
King's Health Partners Confidence in Concept
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2217/bmt-2020-0010
Publication URI: http://dx.doi.org/10.2217/bmt-2020-0010
Type: Journal Article/Review
Parent Publication: Breast Cancer Management
Issue: 3